Levokarnitin

When ATH:
A16AA01

Characteristic.

The white crystalline powder;, easily soluble in water, slightly soluble in alcohol.

Pharmacological action.
Anabolic, antihypoxia, antitireoidnoe, stimulating fat metabolism, catalytic regeneration.

Application.

The consequences of birth trauma and asphyxia newborns, malnutrition and neonatal hypotension, respiratory distress syndrome in newborns, nursing preterm infants, located on total parenteral nutrition, and children, which produces hemodialysis; sindromokompleks, similar to Reye's syndrome (gipoglikemiâ, gipoketonemiya, coma), occurs in children while taking valproic acid; underweight in children and adolescents up to 16 years; propionic etc.. "Organic" acidemia, primary (genetic) and secondary carnitine deficiency, incl. in patients with chronic renal failure, hemodialysis; mild form of hyperthyroidism, exogenous constitutional obesity, psoriasis, seborrhea, cutaneous form of scleroderma, cardiomyopathy, miokardit, CHD (angina, acute myocardial infarction, postinfarction state), hypoperfusion in cardiogenic shock, myopathies, anorexia, chronic gastritis hypoacid, Chronic pancreatitis with exocrine violation, liver disease, neurasthenia, traumatic encephalopathy, physical exhaustion, intense exercise in athletes (as an anabolic and adaptogen), prevention of cardiac toxicity in the treatment of anthracycline.

Contraindications.

Hypersensitivity.

Side effects.

Pain in the epigastric region, dyspepsia, muscular weakness.

Cooperation.

Glucocorticoids contribute to the accumulation in the tissues (except liver), other anabolic steroids enhance the effect of.

Dosing and Administration.

Inside, I /. Inside, for 30 minutes before eating, diluting with water, tea, kiselem, adults 2-3 times a day for 1/2-2 c.logki 20% solution or chewable Table 1-2. For ease of use in neonates bred before use 3 ml 20% solution 200 ml 5% glucose solution and the solution obtained appoint 10-20 ml (2-4 c.logki) 23 times per day for 30 minutes before feeding. At the end of the neonatal period to 1 Year appoint 10 drops 20% solution, children 1-6 years 14 drops, 6-12 Years - 1/4 c.logki 2-3 times a day. B /, slowly, in acute myocardial infarct in a daily dose of 100-200 mg/kg 4 admission or as a continuous infusions over 48 hours followed by a reduction in dose 2 times; sick, in chronic gemodialise- 2 g once immediately after the conclusion of the next session.